Become an affiliate

Do you own a website or blog, or have a social media profile? You could be earning extra money by becoming an affiliate to Undervalued-Shares.com.

The Undervalued-Shares.com affiliate programme is a way for me to reward you for any sales made from traffic you've sent to my site.

How it works 

It's easy and free to join:

  1. Contact me to apply.
  2. Promote Undervalued-Shares.com content to your audience.
  3. Visitors follow the links you provide to Undervalued-Shares.com and purchase a Membership.
  4. Receive commission from sales made via that link each month.

Uniquely, I pay my affiliates a recurring, unchanged annual fee throughout the lifetime of subscribers. For each sale that sees a renewal, you will get the same affiliate fee again. No decreasing amount, no limit to the number of years. You will also benefit if a Membership is upgraded to a higher level, and if your leads convert at a later stage (i.e. after they've signed up to my free weekly newsletter).

Your affiliate marketing income from Undervalued-Shares.com could build up to become a significant annual royalty payment. I value long-term relationships, both with my Members and my affiliates.

Affiliates gain complete transparency over the traffic and sales, and can manage their affiliate account online.

Anyone can join*

All you need is your own website, blog or social media profile.

You can promote Undervalued-Shares.com in whatever way works best for you – a link on your blog, a banner, a blog and/or social media post, through your newsletter, or any combination of methods.

I am also open to producing joint videos or similar content, if our respective content allows.

* Each application is vetted and I reserve the right to refuse any application without giving any reason.

Already an affiliate?

Log into the affiliate area to manage your account.

Most recent

Latest reports (for Members only)

2-2.5x from an investment holding liquidation

2-2.5x from an investment holding liquidation

This AIM-listed small-cap will likely return all its capital to shareholders. Underresearched by investors, it's an opportunity that shouldn't even exist – but it does.

Ukraine reconstruction: one stock to benefit

Ukraine reconstruction: one stock to benefit

If or when the war in Ukraine ends, this stock will likely become the focus of investor money pushing into the country.

Actinium-225, aka "the world's rarest drug"

Actinium-225, aka "the world's rarest drug"

This little-known Western European company could become the global market leader for supplying the uber-rare "Ac-225", a potent weapon to treat cancer.